Event Date:
March 12th 3:00 PM - 3:45 PM
Investigating Phenotypic Subtypes and Plasma Biomarkers to Advance Genetic Research on the Heterogeneity of Alzheimer Disease
Research Adviser: Dr. Jonathan Haines
Chair: Dr. Scott Williams
Committee Members: Dana Crawford, Xiaofeng Zhu, Paula Ogrocki
"...Clinically, AD is a complex neurodegenerative disorder characterized by substantial variability in disease onset, progression, and underlying pathology. This heterogeneity complicates accurate diagnosis and effective treatment, emphasizing the need to identify genetic and molecular factors that contribute to AD's complexity...."
Wolstein Research Building (WRB), Room 1223B